When people take the recommended dosing of a drug, they assume it’s the
right amount and safe.
The last 20 years of research on patient adherence in clinical trials
have been reviewed by Dr. Dorothy L. Smith, and she has found that up to 30
percent of clinical trial patients are not taking the full dose or missing them
altogether. In order to find the safest dose, study investigators say it’s very
important that patient adherence in clinical trials need to be higher than that
of the general population.
Unfortunately, some people participating in clinical trials like to
please the study team when it comes to giving feedback. Some do not report that
they had missed doses, and others just don’t give honest answers. The findings
come from the decisions the study patients make and their behavior.
Depending on the results from tests, the dose recommended for the public
could be too high.
According to the article from PRWEB, there are things that can be done in
the clinical trials that would help protect the public.
Study patients should feel comfortable and safe in order to provide
honest feedback about the trials. Study investigators could make it easier for
study patients to remember their role in the research, such as reminding them
to take their doses texts, Smartphone Apps, diaries and detailed instructions.
Also, information given to study patients needs to be easy to read and understand.
Therefore, clinical trial investigators need to develop a strategy where
honest answers are given, and one where study patient adherence is higher than
the general public.
Snyder and
Wenner, P.C.
2200 E.
Camelback Road
Suite 213
Phoenix, AZ
85016
602-224-0005
No comments:
Post a Comment